Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma
- PMID: 29233113
- PMCID: PMC5727877
- DOI: 10.1186/s12876-017-0702-x
Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma
Abstract
Background: Serrated adenocarcinoma (SAC) is a distinct colorectal carcinoma variant that accounts for approximately 7.5% of all advanced colorectal carcinomas. While its prognosis is worse than conventional carcinoma, its early-stage clinicopathologic features are unclear. We therefore aimed to clarify the clinicopathologic and endoscopic characteristics of early-stage SACs.
Methods: Forty consecutive early-stage SAC patients at Hiroshima University Hospital were enrolled; SACs were classified into epithelial serration (Group A, n = 17) and non-epithelial serration (Group B, n = 23) groups. Additionally, we classified serrated adenoma into 4 types: sessile serrated adenoma (SSA), traditional serrated adenoma (TSA), unclassified, and non-serrated adenoma type.
Results: There were significant differences between Groups A and B in terms of tumor size (27.6 vs. 43.1 mm), incidences of T1 carcinoma (71% vs. 13%), and having the same color as normal mucosa (47% vs. 17%), respectively (p <0.01). In SACs >20 mm, the incidence of T1 carcinoma in Group A (70%) was significantly greater than that in Group B (13%) (p <0.05). There were significant differences in 'Japan NBI Expert Team' type 3 and type V pit pattern classifications between the 2 groups. The average TSA-type tumor size (42.6 mm) was significantly larger than that of the SSA (17.2 mm) and non-serrated component types (18.3 mm). The incidences of submucosal invasion in SSA- (80%), unclassified- (100%), and non-serrated-type (100%) tumors were significantly higher than that in the TSA type (11%).
Conclusions: Epithelial serration in the cancerous area and a non-TSA background indicated aggressive behavior in early-stage SACs.
Keywords: Colorectal cancer; Narrow band imaging; Pit pattern; Serrated adenocarcinoma.
Conflict of interest statement
Ethics approval and consent to participate
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Hiroshima University Hospital. Written informed consent was obtained from all patients who participated in this study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma.Virchows Arch. 2018 Mar;472(3):383-393. doi: 10.1007/s00428-017-2234-8. Epub 2017 Sep 19. Virchows Arch. 2018. PMID: 28929387
-
[Clinicopathologic features and proliferative status of colorectal serrated lesions: a study of 104 cases].Zhonghua Bing Li Xue Za Zhi. 2009 Feb;38(2):100-5. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19573354 Chinese.
-
Colonoscopic features and malignant potential of sessile serrated adenomas: comparison with other serrated lesions and conventional adenomas.Colorectal Dis. 2016 Aug;18(8):795-802. doi: 10.1111/codi.13276. Colorectal Dis. 2016. PMID: 26784017
-
Sessile serrated adenoma/polyps: Where are we at in 2016?World J Gastroenterol. 2016 Sep 14;22(34):7754-9. doi: 10.3748/wjg.v22.i34.7754. World J Gastroenterol. 2016. PMID: 27678358 Free PMC article. Review.
-
Endoscopic diagnosis of colorectal serrated lesions: Current status and future perspectives based on the results of a questionnaire survey.Dig Endosc. 2016 Apr;28 Suppl 1:35-42. doi: 10.1111/den.12632. Dig Endosc. 2016. PMID: 26864882 Review.
Cited by
-
Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.PLoS One. 2019 Feb 20;14(2):e0211477. doi: 10.1371/journal.pone.0211477. eCollection 2019. PLoS One. 2019. PMID: 30785889 Free PMC article.
-
WHICH LESIONS ARE AT HIGHER RISK OF DEVELOPING COLORECTAL CARCINOMAS: SUPERFICIALLY ELEVATED SERRATED LESIONS OR DEPRESSED LESIONS?Arq Bras Cir Dig. 2023 Jan 9;35:e1716. doi: 10.1590/0102-672020220002e1716. eCollection 2023. Arq Bras Cir Dig. 2023. PMID: 36629693 Free PMC article.
-
Role of microRNA in colorectal carcinoma (CRC): a narrative review.Ann Med Surg (Lond). 2023 Nov 7;86(1):308-318. doi: 10.1097/MS9.0000000000001494. eCollection 2024 Jan. Ann Med Surg (Lond). 2023. PMID: 38222721 Free PMC article. Review.
References
-
- Bosman FT, Hruban RH, Theise ND. WHO classification of tumors of the digestive system. Lyon, France: International Agency for Research on Cancer; 2010.
-
- García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, Acosta-Ortega J, Trujillo-Santos J, Cerezuela-Fuentes P, et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol. 2010;41:1359–1368. doi: 10.1016/j.humpath.2010.04.002. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials